Conference Coverage

Nicotinamide cuts rate of nonmelanoma skin cancer in those at high risk


 

FROM THE ASCO 2015 PRESSCAST

References

Dr. Damian disclosed no relevant conflicts of interest. The study was funded by the National Health & Medical Research Council.

Pages

Recommended Reading

Handheld device illuminates possible routes of melanoma metastases
MDedge Hematology and Oncology
Teledermoscopy referrals surpass paper for managing skin cancer patients
MDedge Hematology and Oncology
Xerosis is significant risk during targeted anticancer treatments
MDedge Hematology and Oncology
Overall survival plateaus at 3 years for ipilimumab-treated melanoma patients
MDedge Hematology and Oncology
Melanoma incidence highest in Oregon, lowest in Texas in 2015
MDedge Hematology and Oncology
Laser-enhanced 5-FU scores with squamous cell, basal cell patients
MDedge Hematology and Oncology
Avoid voriconazole in transplant patients at risk for skin cancer
MDedge Hematology and Oncology
Melanoma incidence drops for U.S. children and teens
MDedge Hematology and Oncology
VIDEO: Larger lentigo maligna lesions increase risk
MDedge Hematology and Oncology
VIDEO: Updating the immune response to nonmelanoma skin cancer
MDedge Hematology and Oncology